Primary mediastinal large B-Cell lymphoma: A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ('Groupe d'Utude des Lymphomes de l'Adulte') study

American Journal of Surgical Pathology

Volumn 20, Issue 7, 1996, Pages 877-888

  Cazals Hatem, D ^a   Lepage, E ^b   Brice, P ^b   Ferrant, A ^b   D'Agay, M F ^b   Baumelou, E ^b   Briere J ^b   Blanc, M ^b   Gaulard, P ^b   Biron, P ^b   Schlaifer, D ^b   Diebold, J ^b   Audouin, J ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

B cell lymphoma; bcl 2; Epstein Barr virus; Non Hodgkin's lymphoma; Serum lactic dehydrogenase

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOXANTRONE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; RNA ANALYSIS; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; FEMALE; FRANCE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PROGNOSIS;

EID: 8944260901     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199607000-00012     Document Type: Article

References (57)

1. Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin. Histopathology 1986;10:379-90.
2. Al-Sharabati M, Chittal S, Duga-Neulat I, et al. Primary anterior mediastinal B-cell lymphoma: a clinicopathologic and immunohistochemical study of 16 cases. Cancer 1991; 67:2579-87.
3. Bertini M, Orsucci L, Vitolo U, et al. Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol 1991;2:733-7.
4. Borgonovo Brandter L, Smith CIE, Hammarstrom L, Lindermalm CV, Christensson B. Clonal immunoglobulin gene rearrangements in primary mediastinal clear cell lymphomas. Leukemia 1989;3:122-9.
5. Bosly A, Lepage E, Coiffier B, et al. Alternating chemotherapy does not improve results in poor prognosis aggressive lymphomas. LNH87 protocol group 3: a GELA study [Abstract]. Blood 1993;82(suppl. 2):136a.
6. Brittinger G, Bartels H, Common H. et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin's lymphomas. Results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 1984;2: 269-306.
7. Canellos GP, Skarin AT, Klatt MM, et al. The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. Semin Hematol 1987;24(2 Suppl 1):2-7.
8. Chang K, Chen Y, Shibata D, Weiss L. Description of an in situ hybridization methodology for detection of EBV RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1993;4:246-55.
9. Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 1989;7:1018-26.
10. Cox DR. The analysis of binary data. New York, NY: Chapman and Hall, 1970:00-00.
11. Davis RE, Dorfman RF, Warnke RA. Primary large cell lymphoma of the thymus: a diffuse B-cell neoplasm presenting as primary mediastinal lymphoma. Hum Pathol 1990;21: 1262-8.
12. Fend F, Nachbaur D, Oberwasserlechner F, Kreczy A, Huber H, Muller-Hermelink HK. Phenotype and topography of human thymic B-cells: an immunohistologic study. Virchows Arch 1991;860:381-8.
13. Fisher RI, Gay nor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993;328:1002-6.
14. Glickman JN, Howe JG, Steintz JA. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol 1988;62:901-11.
15. Gordon LI, Harrington D, Andersen J, et al. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 1992;327: 1342-9.
16. Haioun C, Gaulard P, Roudot-Thoraval F, et al. Mediastinal diffuse large cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol 1989;12:425-9.
17. Haioun C, Lepage E, Gisselbrecht C, et al. Comparison of autologous bone marrow transplantation (ABMT) with sequential chemotherapy for aggressive non-Hodgkin's lymphoma (NHL) in first complete remission: a study of 464 patients (LNH 87 protocol). A GELA study. J Clin Oncol 1995;(in press).
18. Harris NL, Jaffe ES, Stein H, et al. A revised European - American classification of lymphoïd neoplasms: a proposal from the International Lymphoma Study group. Blood 1994; 84:1361-92.
19. Hermine O, Haioun C, Lepage E, et al. Bcl-2 protein expression in aggressive non-Hodgkin's lymphoma (NHL). A new adverse prognostic factor? A study on 290 cases. Blood (submitted).
20. Hofmann WJ, Nomburg F, Möller P, Otto HF. Intra and extrathymic B cells in physiologic and pathologic conditions. Virchows Arch 1988;A412:431-42.
21. Hui PK, Feller AC, Lennert K. High-grade non-Hodgkin's Lymphoma of B-cell type. I-Histopathology. Histopathology 1988;12:127-43.
22. Isaacson PG, Chan JKC, Tang C, Addis BJ. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. Am J Surg Pathol 1990;14:342-51.
23. Isaacson PG, Norton AJ, Addis BJ. The human thymus contains a novel population of B lymphocytes. Lancet 1987;26: 1488-91.
24. Jacobson JO, Aisenberg AC, Lamarre L, Willet CG, Lingood RM, Miketic LM, Harris NL. Mediastinal large cell lymphoma: an uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988;62:1893-98.
25. Kadin M, Butmarc J, Elovic A, Wrong D. Eosinophils are the major source of transforming growth factor-b1 in nodular sclerosing Hodgkin's disease. Am J Pathol 1993;142:11-6.
26. Kanavaros P, Gaulard P, Charlotte F, et al. Discordant expression of immunoglobulin and its associated molecule MB-1/CD79A is frequently found in mediastinal large B-cell lymphomas. Am J Pathol 1995 (in press).
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:157-81.
28. King SC, Reiman RJ, Prosnitz LR. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease. J Clin Oncol 1994;12:306-11.
29. Kirn D, Mauch P, Shaffer K, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993;11: 1336-43.
30. Lamarre L, Jacobson JO, Aisenberg AC, Harris NL. Primary large cell lymphoma of the mediastinum: a histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 1989;13:730-9.
31. Lavabre-Bertrand T, Donadio D, Fegueux N, et al. A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer 1992;69:2561-6.
32. Lazzarino M, Orlandi E, Paulli M, et al. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 1993;11:2306-13.
33. Lennert K, Feller AC. Histopathologie der non-Hodgkin lymphome (nach der aktualisierten Kiel-Klassifikation). Berlin, Germany: Springer Verlag, 1990:00-00.
34. Lichtenstein AK, Levine A, Taylor CR, et al. Primary Mediastinal Lymphoma in Adults. Am J Med 1980;68:509-14.
35. Menestrina F, Chilosi M, Bonetti F, et al. Mediastinal large-cell lymphoma of B-cell type with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology 1986;10:589-600.
36. Miller JB, Variakojis D, Bitran JD, et al. Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer 1981;47:748-56.
37. Möller P, Lammler B, Eberlein-Gonska M, et al. Primary mediastinal clear-cell lymphoma of B-cell type. Virchows Arch A 1986;409:79-92.
38. Möller P, Matthaei-Maurer DU, Hofmann WJ, Dorken B, Moldenhauer G. Immunophenotypic similarities of mediastinal clear-cell lymphoma and sinusoidal (monocytoid) B-cells. Int J Cancer 1989;43:10-6.
39. Möller P, Moldenhauer G, Momburg F, et al. Mediastinal lymphoma of clear-cell type is a tumor corresponding to terminal steps of B-cell differentiation. Blood 1987;69:1087-95.
40. Nakagawa A, Nakamura S, KoshikawaT, et al. Clinicopathologic study of primary mediastinal non-lymphoblastic non-Hodgkin's lymphomas among the Japanese. Acta Pathol Jpn 1993;43:44-54.
41. Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis: a clinicopathologic study of 60 cases. Am J Surg Pathol 1986;10:176-91.
42. Prévot S, Hamilton-Dutoit S, Audouin J, Walter P, Pallesen G, Diebold J. Analysis of African Burkitt's and high-grade B-cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization. Br J Haemalol 1992;80: 27-32.
43. Rohatiner AZS, Whelan JS, Ganjoo RK, Norton AJ, Wilson A, Lister TA. Mediastinal large-cell lymphoma with sclerosis (MLCLS). Br J Cancer 1994;69:601-4.
44. Rosas-Uribe A, Rappaport H. Malignant lymphoma, histiocytic type with sclerosis (sclerosing reticulum cell sarcoma). Cancer 1972;29:946-53.
45. Rouse R, Warnke R. Special applications of tissue section immunologic staining in the characterization of monoclonal antibodies and in the study of normal and neoplastic tissues. In: Weir DM, Blackwel CL, Herzenberg LA, eds. Handbook of experimental immunology. Edinburgh: Blackwell, 1986:00-00.
46. Scarpa A, Bonetti F, Menestrina F, et al. Mediastinal large cell lymphoma with sclerosis. Genotypic analysis establishes its B nature. Virchows Arch A 1987;412:17-21.
47. Scarpa A, Borgato L, Chilosi M, et al. Evidence of c-myc gene abnormalities in mediastinal large B cell lymphoma of young adult age. Blood 1991;78:780-8.
48. Stanfeld A, Diebold J, Kapanci Y, et al. Update Kiel classification for lymphomas. Lancet 1988;1:292-3.
49. Stein H, Dallenbach F. Diffuse large cell lymphomas of B and T-cell type. In: Knowles DM, eds. Neoplastic hematopathology. Baltimore: Williams & Wilkins, 1992:675-714.
50. The international non-Hodgkin's lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin's lymphoma. N. Engl J Med 1993;329:987-94.
51. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for Clinical Usage. Cancer 1982;49:2112-35.
52. Todeshini G, Ambrosetti A, Meneghini G, et al. Mediastinal large B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 1990;8:804-8.
53. Trump DL, Mann RB. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostic subset of patients with non-Hodgkin's lymphoma. Cancer 1982;50:277-82.
54. Waldron J, Newcomer L, Katz M, Cadman E. Sclerosis variants of follicular center cell lymphomas presenting in the retroperitoneum. Cancer 1983;52:712-20.
55. Weiss L, Warnke R, Sklar J, Cleary M. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987;317:1185-9.
56. Yousem SA, Weiss LM, Warnke RA. Primary mediastinal non Hodgkin's lymphomas. A morphologic and immunologic study of 19 cases. Am J Clin Pathol 1985;83:676-80.
57. Yunis J. The chromosomal basis of human neoplasia. Science 1983;221:227-36.